含羞草社区

?
?
?
?
Home Tags Posts tagged with "Su Lu"

Tag: Su Lu

Structure Therapeutics ADS offering
Deal Highlights

Structure Therapeutics raises USD180m in ADS offering

Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Geographical Indications Protection In The Philippines

Geographical Indications in the Philippines: Recognition to realisation

By Ranielle Evangelista, Federis & Associates Law Offices

Taking TM’s measure

Trademark disputes, regulatory reforms and expansion pressures are forcing businesses to rethink brand protection

Hogan Lovells welcomes back Tao Xin

Pharmaceuticals partner returns to Hogan Lovells in Washington

Calculation of principal and term interest

How principal, interest are calculated and applied in court (Part 1)

By Chen Yanhong, DHH Law?Firm
Japan Whistleblower Protection Act Amendment 2026

Key revisions to Japan’s Whistleblower Protection Act

By Kengo Nishigaki, GI&T Law Office
Teresa Lee joins Gianni & Origoni

Hong Kong-based partner joins Italian firm Gianni & Origoni

Correspondents

Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW
Follow 含羞草社区
Law firms Awards Events Legal jobs ? Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 含羞草社区. All rights reserved.

Follow us on LinkedIn